NCT00885196 2020-12-22
A Dose Finding Study of AEB071 Assessing Psoriasis Area and Severity Index in Patients With Plaque Psoriasis
Novartis
Phase 2 Completed
Clinical Trials
3 trialsNCT01402440 2020-12-19
Study of AEB071 (a Protein Kinase C Inhibitor) in Patients With CD79-mutant Diffuse Large B-Cell Lymphoma
Novartis
Phase 1 Terminated
NCT02285244 2017-04-05
Sotrastaurin Acetate in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, Prolymphocytic Leukemia, or Richter's Transformation
Ohio State University Comprehensive Cancer Center
Phase 2 Withdrawn